Asian Pacific journal of cancer prevention : APJCP · 2009
Overview of chronic myeloid leukemia patients in Pakistan in the pre-imatanib era.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Usmani Saad Z, Yunus Shakeeb A, Jamal Yasser
Аннотация
OBJECTIVE: To study the patient characteristics of patients diagnosed with chronic myelogenous leukemia (CML) at a tertiary care cancer hospital in Pakistan.
METHODS AND MATERIALS: A retrospective analysis was conducted on CML patients treated between 1996 and 2004 at Shaukat Khanum Memorial Cancer Hospital and Research Center.
RESULTS: A total of 461 CML patient charts were reviewed. The mean and median ages at presentation were much younger than in the prior reports in the western literature with a quicker progression of disease.
CONCLUSION: The advent of tyrosine kinase inhibitors will likely have more impact on the lifespan of CML patients in Pakistan when compared with patients in the western hemisphere due to younger age at diagnosis.
METHODS AND MATERIALS: A retrospective analysis was conducted on CML patients treated between 1996 and 2004 at Shaukat Khanum Memorial Cancer Hospital and Research Center.
RESULTS: A total of 461 CML patient charts were reviewed. The mean and median ages at presentation were much younger than in the prior reports in the western literature with a quicker progression of disease.
CONCLUSION: The advent of tyrosine kinase inhibitors will likely have more impact on the lifespan of CML patients in Pakistan when compared with patients in the western hemisphere due to younger age at diagnosis.